Investing

Pre-Market Stock News (MAR 21, 2007)

(ABN) ABN AMRO could get late stage bids from rivals according to WSJ.
(ADBE) Adobe traded up 5% after beating earnings and reaffirming estimates.
(AIR) AAR $0.37 EPS vs $0.37e.
(AMSC) American Superconductor receives $8 million order from Sinovel for additional 1.5 megawatt Wind Turbine Electrical Systems.
(BA) Boeing wins 6 plane order for 777 long haul jets from Virgin.
(CTSH) Cognizant announces a multi-year IT contract with Simon & Schuster.
(DELL) Dell launches a low-cost PC for Chinese market.
(EAGL) EGL confirmed new rival $40 offer from Apollo.
(EBS) Emergent Biosolutions file its INDA with the FDA for its pivotal anthrax immune globulin clinical trial.
(ECTX) ECtel announces that a wireless operator in Venezuela placed a first time purchase order for ECtel’s integrated revenue management solutions (somebody better tell them to get paid upfront).
(FDX) FedEx set to report earnings ($1.33 estimate on EPS & $8.7B on revenues).
(HNZ) HJ Heinz traded up almost 1% after CEO was interviewed by Cramer on Mad Money.
(ICFI) ICF Int’l traded up 20% after blowing away earnings estimates.
(IMAX) Imax signed another theater deal in China.
(JCP) JCPenney up almost 1% after Cramer noted positive on Mad Money.
(MON) Monsanto and BASF announced a R&D and commercialization collaboration pact in plant biotechnology.
(NICE) Nice Systems gets safety and security order with partner Siemens in Belgium for rail.
(ORCL) Oracle traded up 5% after beating earnings estimates.
(PQE) Petroquest will be suspended for trading by NYSE because it does not plan on its annual report being filed on time.
(RIG) Transocean noted positively by Cramer on Mad Money.
(SNDK) SanDisk and Hynix announce patent cross license agreement for flash memory.
(TIN) Temple Inland worth $85 in break-up value according to Cramer.
(TRB) Tribune may be getting a revised bid from Sam Zell according to WSJ; Tribune revenues down 3.4% in February.
(ULBI) Ultralife Batteries receives $1.6 million military battery order fro Dept of Defense.
(VAR) Varian’s brachytherapy applicator update set for esophagus cancer treatment receives FDA 510k clearance.
(XTO) XTO noted as the best wildcatter by Cramer.

Jon C. Ogg
March 21, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.